Voice your opinion on congressional bill HR4400-116 and let lawmakers know your stance with UnPac!

Main Subject: Health

Advancing Education on Biosimilars Act of 2019

This bill requires the Department of Health and Human Services (HHS) to maintain a website and undertake other activities to educate health care providers, patients, and caregivers about biological products, biosimilar biological products, and interchangeable biosimilar biological products.

Among other activities, HHS must develop or improve continuing education programs that address clinical considerations for biological and related products. Health care providers eligible for the Merit-based Incentive Payment System in Medicare may count completion of such a program as a clinical practice improvement activity.

HR19-116, S1895-116, S4796-116, HR8527-116,

House committee actions Actions

Committee
Sep. 20 2019	Referred to the Subcommittee on Health.
Sep. 19 2019	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Sep. 19
2019

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Sep. 19 2019	Introduced in House Introduced in House

House bill HR4400-116

Advancing Education on Biosimilars Act of 2019

Promote the cause!

Or use this QR code